Aerosolized mucosal vaccines show promise in controlling SARS-CoV-2, offering greater protection and immune response than intramuscular bivalent mRNA boosters.
Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections
- Post author:
- Post published:September 5, 2024
- Post category:uncategorized